NCT01348165View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

August 31, 2011

Conditions
Healthy
Interventions
DRUG

BI 137882

Powder for oral solution

DRUG

Placebo

Powder for oral solution

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY